MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $105,983 | +65.0% | 2,433,029 | +36.9% | 0.02% | +77.8% |
Q2 2023 | $64,224 | -2.5% | 1,777,579 | +0.4% | 0.01% | -10.0% |
Q1 2023 | $65,844 | +2.6% | 1,770,941 | +25.0% | 0.01% | 0.0% |
Q4 2022 | $64,191 | -99.9% | 1,416,728 | +24.0% | 0.01% | -23.1% |
Q3 2022 | $79,811,000 | +13.1% | 1,142,755 | +8.7% | 0.01% | +44.4% |
Q2 2022 | $70,589,000 | -47.8% | 1,051,530 | -36.0% | 0.01% | -35.7% |
Q1 2022 | $135,187,000 | -57.6% | 1,644,216 | -24.4% | 0.01% | -51.7% |
Q4 2021 | $319,021,000 | -14.7% | 2,174,799 | +2.9% | 0.03% | -17.1% |
Q3 2021 | $374,025,000 | +20.5% | 2,114,210 | +10.0% | 0.04% | +20.7% |
Q2 2021 | $310,425,000 | +18.2% | 1,921,779 | +25.4% | 0.03% | +11.5% |
Q1 2021 | $262,517,000 | -23.4% | 1,532,500 | -1.7% | 0.03% | -25.7% |
Q4 2020 | $342,510,000 | +57.3% | 1,559,416 | +18.9% | 0.04% | +40.0% |
Q3 2020 | $217,735,000 | +45.7% | 1,311,262 | +0.2% | 0.02% | +31.6% |
Q2 2020 | $149,432,000 | +51.0% | 1,308,852 | +1.6% | 0.02% | +18.8% |
Q1 2020 | $98,981,000 | -44.6% | 1,287,645 | -7.1% | 0.02% | -30.4% |
Q4 2019 | $178,520,000 | +71.4% | 1,385,379 | +3.7% | 0.02% | +53.3% |
Q3 2019 | $104,132,000 | -16.2% | 1,336,564 | +10.8% | 0.02% | -11.8% |
Q2 2019 | $124,233,000 | +107.3% | 1,206,144 | +47.5% | 0.02% | +88.9% |
Q1 2019 | $59,932,000 | +329.2% | 817,628 | +148.4% | 0.01% | +350.0% |
Q4 2018 | $13,963,000 | -9.6% | 329,160 | +0.3% | 0.00% | 0.0% |
Q3 2018 | $15,450,000 | +47.5% | 328,024 | +54.4% | 0.00% | 0.0% |
Q2 2018 | $10,475,000 | +83.1% | 212,465 | +14.0% | 0.00% | +100.0% |
Q1 2018 | $5,720,000 | – | 186,320 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |